The safety of pertussis vaccine
Thomson, K.D.
New Zealand Medical Journal 109(1017): 84
1996
ISSN/ISBN: 0028-8446 PMID: 8606833 Document Number: 455281
Document emailed within 1 workday
Related Documents
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868
Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Isomura, S. 1991: Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan Developments in Biological Standardization 73: 37-42
Bose, A.; Dubey, A.P.; Gandhi, D.; Pandit, A.; Raghu, M.B.; Raghupathy, P.; Rao, M.I.S.; Verghese, V.P.; Datta, S.K.; Bock, H.L. 2007: Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children Indian Pediatrics 44(6): 421-424
Huu, T.Ngoc.; Phuong, N.Thi.Minh.; Toan, N.Trong.; Thang, H.Vinh. 2015: Immunogenicity and Safety of Quinvaxem® (Diphtheria, Tetanus, Whole-Cell Pertussis, Hepatitis B and Haemophilus Influenzae Type B Vaccine) Given to Vietnamese Infants at 2 to 4 Months of Age Southeast Asian Journal of Tropical Medicine and Public Health 46(4): 753-763
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41
Mortimer, E.A. 1990: Pertussis and pertussis vaccine: 1990 Advances in Pediatric Infectious Diseases 5: 1-33
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Kerdpanich, A.; Hutagalung, Y.; Watanaveeradej, V.; Bock, H.L.; Steinhoffmd, M. 2007: The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine Journal of the Medical Association of Thailand 90(7): 1330-1336
Frühwirth, M.; Wolf, H.; Heininger, H.; Guggenbichler, J.P.; Stehr, E. 1995: Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis Advances in Experimental Medicine and Biology 371b: 777-783
Wannered, L. 1996: Misleading information on pertussis vaccine Lakartidningen 93(12): 1102
Ashkenazi, S.; Danon, Y.L.; Nitzan, M. 1987: A new pertussis vaccine--necessity and efficacy Harefuah 113(9): 264-266